Fibromyalgia Syndrome: Oxford Rheumatology Library
Autor Ernest Choyen Limba Engleză Paperback – 24 sep 2015
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (2) | 150.33 lei 10-16 zile | |
OUP OXFORD – 24 sep 2015 | 150.33 lei 10-16 zile | |
Oxford University Press – 25 mar 2009 | 150.62 lei 41-52 zile |
Preț: 150.33 lei
Preț vechi: 186.70 lei
-19% Nou
Puncte Express: 225
Preț estimativ în valută:
28.77€ • 29.85$ • 24.05£
28.77€ • 29.85$ • 24.05£
Carte disponibilă
Livrare economică 11-17 februarie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780198723233
ISBN-10: 0198723237
Pagini: 80
Dimensiuni: 137 x 196 x 5 mm
Greutate: 0.09 kg
Ediția:2 Rev ed.
Editura: OUP OXFORD
Colecția OUP Oxford
Seria Oxford Rheumatology Library
Locul publicării:Oxford, United Kingdom
ISBN-10: 0198723237
Pagini: 80
Dimensiuni: 137 x 196 x 5 mm
Greutate: 0.09 kg
Ediția:2 Rev ed.
Editura: OUP OXFORD
Colecția OUP Oxford
Seria Oxford Rheumatology Library
Locul publicării:Oxford, United Kingdom
Recenzii
Review from previous edition This pocket book represents a handy and practical tool for rheumatologists and general practitioners aimed at facilitating the diagnosis and the management of fibromyalgia syndrome in daily practice.
This is a most helpful and comprehensive little book.
This is a most helpful and comprehensive little book.
Notă biografică
Ernest Choy is Professor of Rheumatology at the Cardiff Institute of Infection & Immunity. He has a major research interest in experimental medicine and clinical trial design in rheumatic diseases, and has conducted many proof-of-concept, first in human clinical trials in inflammatory arthritis. Professor Choy has served as Chief Investigators of many clinical trials which have been funded by Medical Research Council, Arthritis Research UK, NIHR Health Technology Assessment, Arthritis Research UK and pharmaceutical companies. He is also interested in improving the assessment of disease by developing better outcome measures. He has served as chair to a number of working groups in the Outcome Measures for Rheumatology organisation.